Your browser doesn't support javascript.
loading
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies.
Liang, Yi; Jeganathan, Sujeeve; Marastoni, Stefano; Sharp, Adam; Figueiredo, Ines; Marcellus, Richard; Mawson, Amanda; Shalev, Zvi; Pesic, Aleksandra; Sweet, Joan; Guo, Haiyang; Uehling, David; Gurel, Bora; Neeb, Antje; He, Housheng Hansen; Montgomery, Bruce; Koritzinsky, Marianne; Oakes, Samantha; de Bono, Johann S; Gleave, Martin; Zoubeidi, Amina; Wouters, Bradly G; Joshua, Anthony M.
Afiliação
  • Liang Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Jeganathan S; Quality Control Analytical Excellence, Sanofi Pasteur, Toronto, Ontario, Canada.
  • Marastoni S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Sharp A; Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Figueiredo I; The Institute of Cancer Research, London, United Kingdom.
  • Marcellus R; The Institute of Cancer Research, London, United Kingdom.
  • Mawson A; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Shalev Z; Garvan Institute of Medical Research, Sydney, Australia.
  • Pesic A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Sweet J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Guo H; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
  • Uehling D; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Gurel B; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Neeb A; The Institute of Cancer Research, London, United Kingdom.
  • He HH; The Institute of Cancer Research, London, United Kingdom.
  • Montgomery B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Koritzinsky M; Department of Medicine and Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington.
  • Oakes S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • de Bono JS; Department of Radiation Oncology, Department of Medical Biophysics, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Gleave M; Garvan Institute of Medical Research, Sydney, Australia.
  • Zoubeidi A; Faculty of Medicine, UNSW Sydney, Australia.
  • Wouters BG; Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Joshua AM; The Institute of Cancer Research, London, United Kingdom.
Clin Cancer Res ; 27(8): 2340-2351, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33542074
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-bcl-2 / Quinase I-kappa B / Neoplasias de Próstata Resistentes à Castração / Nitrilas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-bcl-2 / Quinase I-kappa B / Neoplasias de Próstata Resistentes à Castração / Nitrilas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá